Nasdaq Jumps 250 Points; Crude Oil Down 1%

Benzinga04-12

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging more than 250 points on Thursday.

The Dow traded up 0.18% to 38,532.50 while the NASDAQ rose 1.63% to 16,433.83. The S&P 500 also rose, gaining, 0.83% to 5,203.26.

Check This Out: How To Earn $500 A Month From Citigroup Stock Ahead Of Q1 Earnings Report

Leading and Lagging Sectors

Information technology shares rose by 2.2% on Thursday.

In trading on Thursday, energy shares fell by 0.3%.

Top Headline

Constellation Brands Inc (NYSE:STZ) reported better-than-expected fourth-quarter earnings.

Constellation Brands reported fourth-quarter FY24 sales growth of 7.1% year-on-year to $2.14 billion, beating the analyst consensus estimate of $2.10 billion. Comparable EPS, excluding Canopy EIE, was $2.30. Comparable EPS of $2.26 beat the consensus estimate of $2.09.

Equities Trading UP

Rallybio Corporation (NASDAQ:RLYB) shares shot up 87% to $3.0419 after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant individuals at risk of FNAIT.

Shares of Eliem Therapeutics, Inc. (NASDAQ:ELYM) got a boost, surging 58% to $4.2153. The company announced that it entered into a definitive acquisition agreement to acquire Tenet and it also entered into a securities purchase agreement for a $120 million private placement.

Rent the Runway, Inc. (NASDAQ:RENT) shares were also up, gaining 128% to $16.88 after the company reported mixed fourth-quarter financial results and issued guidance.

Equities Trading DOWN

Aptevo Therapeutics Inc. (NASDAQ:APVO) shares dropped 59% to $0.9870 after the company priced its $4.6 million public offering.

Shares of Enlivex Therapeutics Ltd. (NASDAQ:ENLV) were down 54% to $1.83. The company announced topline results of its Phase II trial evaluating Allocetra in sepsis.

AVITA Medical, Inc. (NASDAQ:RCEL) was down, falling 29% to $10.20 after the company announced an update to its expected commercial revenue for the first quarter of 2024. BTIG downgraded the stock from Buy to Neutral.

Also Check This Out: Top 3 Financial Stocks That Are Ticking Portfolio Bombs

Commodities

In commodity news, oil traded down 1.1% to $85.29 while gold traded up 1.3% at $2,379.80.

Silver traded up 1.4% to $28.430 on Thursday, while copper fell 0.5% to $4.2605.

Euro zone

European shares were lower today. The eurozone’s STOXX 600 fell 0.40%, London’s FTSE 100 fell 0.47% while Spain’s IBEX 35 Index fell 1.16% The German DAX fell 0.79% French CAC 40 fell 0.27% while Italy’s FTSE MIB Index fell 0.96%.

The European Central Bank kept interest rates unchanged for a fifth straight time during its April meeting.

Asia Pacific Markets

Asian markets closed mixed on Thursday, with Japan’s Nikkei 225 falling 0.35%, Hong Kong’s Hang Seng Index dropping 0.26%, China’s Shanghai Composite gaining 0.23% and India’s S&P BSE Sensex gaining 0.47%.

China's consumer prices rose 0.1% year-over-year in March, while producer prices fell by 2.8% year-over-year in March.

Economics

Producer prices in the U.S. rose 0.2% month-over-month in March compared to a 0.6% gain in February. However, analysts were expecting a gain of 0.3%.

U.S. initial jobless claims declined by 11,000 to 211,000 in the week ending April 6, compared to market estimates of 215,000.

Now Read This: Citigroup Likely To Report Lower Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment